Why OptimalAmino Has 8 Essential Amino Acids Instead of 9

Histidine is essential. It's also the one essential amino acid your body can supply on its own — for weeks.

If you've looked closely at OptimalAmino's label, you may have noticed something: it contains eight essential amino acids, not nine. The "missing" one is histidine. This isn't an oversight — it's a deliberate formulation decision rooted in a genuine biological quirk that makes histidine unlike every other EAA.

The Master Amino Acid Pattern (MAP) — the specific ratio of amino acids used in OptimalAmino — was designed around a single principle: maximize the proportion of ingested amino acid nitrogen that goes toward building body proteins, and minimize the proportion lost as metabolic waste. To understand why that principle leads to excluding histidine, you need to understand what makes histidine biologically unique among the essential amino acids.

The long road to "essential": histidine's unusual classification history

For decades, histidine wasn't considered essential for adults at all. William Cumming Rose's landmark nitrogen balance experiments in the early 1950s — the studies that originally defined which amino acids humans must obtain from diet — tested each amino acid by removing it and observing whether subjects went into negative nitrogen balance. Rose's studies typically lasted only 6–8 days. That was long enough to reveal deficiency for leucine, lysine, methionine, and the other seven. But histidine removal produced no measurable effect over that timeframe. Rose concluded histidine was dispensable for adults.

It took another two decades to prove him wrong. Kopple and Swendseid (1975) conducted the definitive study in the Journal of Clinical Investigation. Four healthy men and three chronically uremic men consumed a histidine-free diet for approximately 35 days in a metabolic ward. The results were unambiguous: plasma histidine fell by 82%, hemoglobin dropped significantly, serum albumin declined in six of seven subjects, and nitrogen balance turned progressively negative — but only after 20–30 days. All abnormalities reversed when histidine was restored.

Cho et al. (1984) extended the timeline further. Seven young men consumed near-zero histidine for eight weeks. Mean nitrogen balance became negative only toward the end of the study period. And Kriengsinyos et al. (2002) confirmed these kinetics with modern isotopic tracer methods in The Journal of Nutrition, documenting a 24–28% decline in whole-body protein turnover, a 12% drop in albumin, and an 11% hemoglobin reduction — all developing gradually over 48 days on a histidine-free diet.

Compare that to lysine. In Wixom and colleagues' (1977) total parenteral nutrition study, removing lysine produced marked negative nitrogen balance within three days. Removing histidine from the same protocol for 27 days produced only near-zero balance — not yet overtly negative.

The WHO/FAO/UNU Expert Consultation formally recognized histidine as essential in 1985, and the U.S. Institute of Medicine set the Recommended Dietary Allowance at 14 mg/kg/day in 2002. Histidine is essential. The question is whether it needs to be in a supplement designed for acute use.

The body's histidine reserves: 87 grams and counting

The reason histidine takes weeks to deplete while other EAAs take days comes down to reservoir biology. Your body maintains enormous histidine stores that no other essential amino acid can match.

Hemoglobin is an enormous histidine bank. The adult body contains roughly 750 grams of hemoglobin, and histidine constitutes approximately 8.5% of hemoglobin by weight — about 38 histidine residues per hemoglobin tetramer. This sequesters roughly 64 grams of histidine. With a red blood cell lifespan of 120 days, normal hemoglobin catabolism releases approximately 530 mg of histidine daily through routine recycling in the spleen and liver. That single source nearly matches the entire estimated daily dietary requirement of 700–1,000 mg.

Muscle carnosine provides a second depot. Carnosine (β-alanyl-L-histidine) is present at concentrations of approximately 5 mmol/kg in skeletal muscle, predominantly in type II glycolytic fibers. Across roughly 30 kg of muscle, this amounts to about 23 grams of stored histidine. The washout half-life of carnosine is 5–9 weeks, as documented by Baguet et al. (2009) in the Journal of Applied Physiology — making it a slow-release reserve. Kriengsinyos's 2002 study documented increased urinary β-alanine during histidine depletion, confirming that carnosine was being broken down to supply free histidine.

Metabolic adaptation extends the runway further. During histidine restriction, the body downregulates histidine oxidation and reduces whole-body protein turnover by 24–28%, effectively rationing the available supply. Some limited endogenous histidine synthesis has been demonstrated using nitrogen-15 tracers, though it's insufficient to meet full requirements indefinitely.

Together, these mechanisms mean the body can maintain adequate intracellular histidine levels for protein synthesis across weeks of zero dietary histidine — a feat impossible for any other essential amino acid.

What this means for muscle protein synthesis

The practical question for an EAA supplement is straightforward: does histidine availability limit the rate of muscle protein synthesis in the hours after ingestion?

The existing evidence says no. Church et al. (2020) analyzed the relationship between individual essential amino acid plasma concentrations and postprandial muscle fractional synthetic rate in Nutrients. Peak plasma concentrations of leucine, isoleucine, valine, and phenylalanine all showed significant positive correlations with MPS. Peak histidine concentration did not. This is exactly what the reservoir biology predicts: because intracellular histidine pools remain replete from endogenous turnover, fluctuations in plasma histidine from exogenous supplementation don't meaningfully constrain the rate at which muscle fibers assemble new proteins.

It's worth noting that many of the landmark MPS tracer studies — the foundational research establishing how EAAs stimulate muscle protein synthesis — used formulations that varied in their histidine content. Tipton et al. (2001) used 6 grams of EAAs with histidine at 10.8% of the mixture. Dreyer et al. (2008) included histidine at 8%. More recent formulations from the same research group include histidine at just 1.5%. None of these studies identified histidine as a rate-limiting factor for the acute MPS response.

The 2023 ISSN Position Stand on EAA supplementation acknowledges histidine's involvement in Rag A/B GTPase phosphorylation for mTORC1 signaling but does not identify it as a primary rate-limiting activator of muscle protein synthesis — that role belongs to leucine.

The nitrogen efficiency principle

The MAP formulation's design logic follows a well-established biochemical principle: when dietary amino acids arrive in proportions that don't match the body's synthetic requirements, the amino acid present in the lowest relative proportion — the "limiting" amino acid — sets the ceiling for protein synthesis. Every amino acid supplied beyond this ceiling is deaminated, its carbon skeleton burned for energy, and its nitrogen converted to urea at a metabolic cost.

If histidine is genuinely non-rate-limiting because of endogenous reserves, then including it in an EAA mixture displaces space that could go to amino acids that are rate-limiting — leucine, lysine, threonine, and the others. The result, in theory, is a formula that directs a higher fraction of its amino acid content directly into protein synthesis with less metabolic waste.

This logic is internally coherent and grounded in real biochemistry. The MAP formulation was developed through nitrogen balance optimization studies beginning in the early 1970s, with the specific ratios refined over approximately two decades of iterative testing by Prof. Dr. Maurizio Lucà-Moretti through the International Nutrition Research Center.

What the published research shows — and what it doesn't

Several published studies have tested the MAP formulation directly. A comparative, double-blind, triple-crossover trial in 66 subjects over 12 weeks measured nitrogen utilization across different protein sources, with MAP showing the highest retention (Lucà-Moretti, 1998). Additional published studies include an athlete comparison trial and a desert-crossing endurance case study, both in Advances in Therapy (2003), plus two multicentric trials testing MAP as a sole protein substitute during weight loss (Lucà-Moretti et al., 2003a; 2003b).

An important caveat: the foundational clinical data from the 1970s and 1980s — the period when the specific amino acid ratios were being iteratively optimized — has never been made publicly available. The published studies represent later-stage validation work, not the raw optimization data. The original clinical datasets, subject-level nitrogen balance records, and iterative ratio-testing protocols from this two-decade development period remain proprietary to the INRC. This means the foundational evidence for MAP's specific ratio — the data that would allow independent scientists to evaluate exactly why these proportions were chosen — cannot be independently assessed. The published validation studies demonstrate outcomes consistent with the claimed efficiency, but the complete developmental evidence base remains inaccessible.

That said, the MAP formula has an extensive real-world track record. Products built on this specific amino acid ratio have been used by millions of consumers across multiple brands and markets for over three decades, with consistent reports of clinical and athletic outcomes that align with the published efficiency claims. Real-world efficacy over that timeframe and scale is meaningful data in its own right — even when the formal evidence base has gaps.

At OptimalAmino, we believe the right response to evidence gaps isn't to ignore them or to paper over them with marketing — it's to fund the research that fills them. That's why we're currently sponsoring university-led research at the University of Tampa Human Performance Lab, designed to investigate EAA applications through rigorous randomized controlled trials. Beyond Tampa, we're actively developing a pipeline of additional studies with other research universities to explore novel applications of OptimalAmino — areas where the existing EAA literature suggests strong mechanistic rationale but where controlled human data doesn't yet exist. Our goal is to generate the kind of independent, peer-reviewed data that the EAA space needs: properly powered studies with validated endpoints, conducted by researchers with no financial stake in the outcome. As those results are published — whether they confirm our expectations or challenge them — we'll share them here.

Additionally, Net Nitrogen Utilization (NNU) — the metric MAP uses to quantify its efficiency advantage — is not a standard measure recognized by the FAO, WHO, or mainstream protein quality frameworks like PDCAAS and DIAAS. This doesn't invalidate the concept, but it does mean the specific efficiency figures aren't directly comparable to conventional protein quality metrics.

Histidine matters — just not for this

None of this diminishes histidine's biological importance. It's a critical amino acid with functions that extend well beyond muscle protein synthesis.

Histidine is the sole precursor to histamine — a molecule essential for gastric acid secretion, immune signaling through mast cells, and neurotransmission governing wakefulness and appetite. It's a structural component of hemoglobin, where proximal and distal histidine residues are required for oxygen binding and the Bohr effect. In muscle, histidine combines with β-alanine to form carnosine, which provides 10–20% of intramuscular pH buffering capacity — directly relevant to high-intensity exercise performance. And histidine's unique imidazole side chain makes it the only amino acid that functions as an effective physiological pH buffer at near-neutral pH.

Blancquaert et al. (2017) demonstrated in Medicine & Science in Sports & Exercise that chronic β-alanine supplementation — popular among athletes for carnosine loading — depletes plasma histidine by approximately 31%, highlighting that histidine availability can become rate-limiting for carnosine synthesis even in well-fed individuals. Brosnan and Brosnan (2020) provided a comprehensive review of histidine metabolism and its physiological roles in Current Opinion in Clinical Nutrition and Metabolic Care.

These functions are real and important. They're also not the question an EAA supplement formula is designed to answer. The question is: when you take a bolus of amino acids to stimulate muscle protein synthesis, does including histidine improve that specific outcome? The evidence says it doesn't need to — your body has it covered, at least for any reasonable duration of supplementation.

The bottom line

OptimalAmino uses the MAP ratio — eight essential amino acids formulated to maximize the fraction of ingested nitrogen that goes toward building body proteins. Histidine is excluded not because it's unimportant, but because your body maintains massive endogenous reserves in hemoglobin (~64 g) and muscle carnosine (~23 g) that supply histidine for protein synthesis without exogenous supplementation. The depletion studies are clear: removing histidine from the diet produces no measurable impairment to protein metabolism for 20–30 days, while removing other EAAs like lysine causes negative nitrogen balance within 72 hours.

Whether histidine is "technically essential" is settled science — it is. Whether it needs to be in a formula designed to maximize acute anabolic efficiency is a different question, and the biology consistently points to no.

References

1. Kopple JD, Swendseid ME. Evidence that histidine is an essential amino acid in normal and chronically uremic man. J Clin Invest. 1975;55(5):881-891. PubMed
2. Cho ES, Anderson HL, Wixom RL, et al. Long-term effects of low histidine intake on men. J Nutr. 1984;114(2):369-384. PubMed
3. Kriengsinyos W, Wykes LJ, Ball RO, Pencharz PB. Long-term effects of histidine depletion on whole-body protein metabolism in healthy adults. J Nutr. 2002;132(11):3340-3348. PubMed
4. Wixom RL, Laidlaw SA, Gruenke LD, et al. Total parenteral nutrition with selective histidine depletion in man. I. Responses in nitrogen metabolism and related areas. Am J Clin Nutr. 1977;30(12):2043-2058. PubMed
5. Baguet A, Reyngoudt H, Pottier A, et al. Carnosine loading and washout in human skeletal muscles. J Appl Physiol. 2009;106(3):837-842. PubMed
6. Church DD, Hirsch KR, Park S, et al. Essential amino acids and protein synthesis: insights into maximizing the muscle and whole-body response to feeding. Nutrients. 2020;12(12):3717. PubMed
7. Tipton KD, Rasmussen BB, Miller SL, et al. Timing of amino acid-carbohydrate ingestion alters anabolic response of muscle to resistance exercise. Am J Physiol Endocrinol Metab. 2001;281(2):E197-E206. PubMed
8. Dreyer HC, Drummond MJ, Pennings B, et al. Leucine-enriched essential amino acid and carbohydrate ingestion following resistance exercise enhances mTOR signaling and protein synthesis in human muscle. Am J Physiol Endocrinol Metab. 2008;294(2):E392-E400. PubMed
9. Ferrando AA, Wolfe RR, Hirsch KR, et al. International society of sports nutrition position stand: essential amino acid supplementation. J Int Soc Sports Nutr. 2023;20(1):2263409. PubMed
10. Lucà-Moretti M. A comparative, double-blind, triple crossover net nitrogen utilization ratio study confirmed the discovery of the master amino acid pattern. Ann R Acad Med Spain. 1998;115:397-416. PubMed
11. Lucà-Moretti M, Grandi A, Lucà E, et al. Comparative results between two groups of track-and-field athletes with or without the use of Master Amino acid Pattern as protein substitute. Adv Ther. 2003;20(4):195-202. PubMed
12. Lucà-Moretti M, Grandi A, Lucà E, et al. Results of taking Master Amino acid Pattern as a sole and total substitute of dietary proteins in an athlete during a desert crossing. Adv Ther. 2003;20(4):203-210. PubMed
13. Lucà-Moretti M, Grandi A, Lucà E, et al. Reduction of body weight by a caloric restriction combined with the use of Master Amino acid Pattern: a multicentric, double-blind, randomized clinical trial. I. Adv Ther. 2003;20(6):351-367. PubMed
14. Lucà-Moretti M, Grandi A, Lucà E, et al. Reduction of body weight by a caloric restriction combined with the use of Master Amino acid Pattern: a multicentric, double-blind, randomized clinical trial. II. Adv Ther. 2003;20(6):368-384. PubMed
15. Blancquaert L, Everaert I, Missinne M, et al. Effects of histidine and β-alanine supplementation on human muscle carnosine storage. Med Sci Sports Exerc. 2017;49(3):602-609. PubMed
16. Brosnan ME, Brosnan JT. Histidine metabolism and function. J Nutr. 2020;150(Suppl 1):2570S-2575S. PubMed